Direct anti-proliferative effect of adipose-derived mesenchymal stem cells of ankylosing spondylitis patients on allogenic CD4+ cells
Guardado en:
Autores principales: | Ewa Kuca-Warnawin, Magdalena Plebańczyk, Krzysztof Bonek, Ewa Kontny |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a950a77981f4c27bbbacb091d7f082c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Calcium physiology, metabolism and supplementation: a glance at patients with ankylosing spondylitis
por: Rossella Talotta, et al.
Publicado: (2020) -
Relationship between periodontal status and disease activity in patients with ankylosing spondylitis
por: Ayşe Ünal Enginar, et al.
Publicado: (2021) -
Trabecular Bone Score (TBS) in Patients with Early Ankylosing Spondylitis—Limited Utility
por: Anna Nowakowska-Płaza, et al.
Publicado: (2021) -
Expansion of myeloid-derived suppressor cells in the peripheral blood of patients with ankylosing spondylitis
por: A. Yu. Morenkova, et al.
Publicado: (2021) -
Advances in nanomedicine for the treatment of ankylosing spondylitis
por: Xi Y, et al.
Publicado: (2019)